Cognitive Enhancement Stack
Selank + Semax
Enhance cognitive function, reduce anxiety, and support neuroprotection
Overview
A dual nootropic approach combining two well-studied Russian peptides. Selank provides anxiolytic and mood-stabilizing effects through GABA modulation, while Semax enhances neurotrophic factor expression (BDNF, NGF) for cognitive enhancement and neuroprotection. Both are administered intranasally for direct CNS access.
Component Peptides
Anxiolytic nootropic — modulates GABA system, reduces anxiety without sedation, stabilizes enkephalin metabolism
Neurotrophic enhancer — increases BDNF and NGF expression, improves attention, memory, and cognitive processing speed
Expected Timeline
Anxiolytic effects from Selank within days. Cognitive enhancement from Semax typically noticed within 1-2 weeks. Peak cognitive benefits at 3-4 weeks of consistent use.
Safety Notes
- Both peptides have excellent safety profiles in clinical use
- Selank is non-addictive and does not cause dependence, unlike benzodiazepines
- Semax may cause mild headache or nasal irritation initially
- Avoid Semax in the evening as it may interfere with sleep in sensitive individuals
- Not WADA-prohibited (as of current listings)
Bloodwork Recommendations
- No specific bloodwork required for these peptides
- Consider baseline cognitive testing for objective measurement
- Thyroid panel if combining with other nootropics
Contraindications
- Active psychotic disorders
- Concurrent use of strong GABA-ergic drugs (benzodiazepines) — consult physician
- Pregnancy or breastfeeding
- Seizure disorders (Semax may lower seizure threshold in rare cases)
Evidence Assessment
Both peptides have been studied in human clinical trials in Russia and are approved medications there. Selank is registered in Russia for generalized anxiety disorder. Semax is used clinically for stroke recovery, cognitive disorders, and as a nootropic. Western peer-reviewed literature is limited, but existing studies show consistent neurotrophic and anxiolytic effects.
References
- Semenova TP, et al. "Effect of Selank on cognitive processes after a single administration." Bull Exp Biol Med. 2009;148(4):621-623.
- Eremin KO, et al. "Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents." Neurochem Res. 2005;30(12):1493-1500.
- Medvedeva EV, et al. "The peptide semax affects the expression of genes related to the immune and vascular systems." Gene. 2013;529(2):261-266.
Research Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. All products referenced are for in vitro laboratory research use only. Consult a qualified healthcare professional before beginning any research protocol.